These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 214701)

  • 1. [Dose-effect of beta-sitosterin in type IIa and IIb hypercholesterolemias (author's transl)].
    Schwartzkopff W; Jantke HJ
    MMW Munch Med Wochenschr; 1978 Nov; 120(47):1575-8. PubMed ID: 214701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
    Mühlfellner G; Mühlfellner O; Kaffarnik H
    Med Klin; 1976 Apr; 71(18):775-8. PubMed ID: 178987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias].
    Kaffarnik H; Mühlfellner G; Mühlfellner O; Schneider J; Hausmann L; Zöfel P; Schubotz R; Fuchs F
    Fortschr Med; 1977 Dec; 95(46):2785-7. PubMed ID: 590905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate.
    Becker M; Staab D; Von Bergman K
    Pediatrics; 1992 Jan; 89(1):138-42. PubMed ID: 1727999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.
    Weisweiler P; Heinemann V; Schwandt P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):204-6. PubMed ID: 6715090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
    Locker PK; Jungbluth GL; Francom SF; Hughes GS
    Clin Pharmacol Ther; 1995 Jan; 57(1):73-88. PubMed ID: 7828385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypolipidemic action of liposome-incorporated beta-sitosterol on rats].
    Mironova VN; Datsenko ZM; Kokunin VA; Kalashnikova LA
    Farmakol Toksikol; 1984; 47(4):71-4. PubMed ID: 6479317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-sitosterol in the treatment of hypercholesterolemia].
    Zák A; Zeman M; Vítková D; Hrabák P; Tvrzická E
    Cas Lek Cesk; 1990 Oct; 129(42):1320-3. PubMed ID: 2257580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols.
    Clifton PM; Mano M; Duchateau GS; van der Knaap HC; Trautwein EA
    Eur J Clin Nutr; 2008 Aug; 62(8):968-77. PubMed ID: 17538539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)].
    Adam O; Wolfram G; Lang PD; Zöllner N
    MMW Munch Med Wochenschr; 1979 Mar; 121(9):319-22. PubMed ID: 106264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
    Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
    Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Cattin L; Da Col PG; Fonda M; Mazzone C; Pertot P
    G Clin Med; 1990 Feb; 71(2):99-104. PubMed ID: 2347462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypolipidemic action of beta-D-glycoside beta-sitosterol in the rat].
    Mironova VN; Kalashnikova LA
    Farmakol Toksikol; 1982; 45(6):45-7. PubMed ID: 7151999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.